HPV Vaccination in Special Risk Groups: 5 Year Follow-up

TerminatedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
PRD (Paediatric Rheumatological Disease)IBD (Inflammatory Bowel Disease)
Trial Locations (1)

2106

Royal Childrens Hospital, Melbourne

All Listed Sponsors
collaborator

Monash Medical Centre

OTHER

lead

Murdoch Childrens Research Institute

OTHER